Bayer strengthens its corporate structure with new appointments

Bayer strengthens corporate structure with new appointments. Sabine İlknur Hırçın, who has been serving as Country Group Quality Director for Turkey, Iran and Israel, was appointed to the position of Middle East and Africa Country Group Quality Director as of February. Sabine İlknur Hırçın, adding another success to her track record at Bayer, has had her scope of responsibilities expanded with this new appointment. While Hırçın will continue her responsibilities regarding Turkey and Iran, she will lead a region covering 63 countries including the United Arab Emirates, Saudi Arabia, Egypt, Nigeria, Kenya, Morocco, Algeria and South Africa. Sabine İlknur Hırçın graduated from Istanbul University as a pharmacist in 1985 and completed her Business Administration specialization program at Istanbul University's Faculty of Business Administration in 1994-1995. Starting her career at Bayer's Parenteral Division as Production Manager in 1990, Hırçın worked as Quality Assurance Manager and Responsible Manager between 2001 and 2007. Following senior management positions at Bayer, she served as Country Group Quality Director for Turkey and Israel from 2021 to 2023.   About Bayer is a global company specializing in life sciences in the fields of health and nutrition. In line with its mission of "Health for All, Zero Hunger," the company aims to support people and the planet we live on by contributing solutions through its products and services to the important challenges of our time due to the growing and aging global population. Committed to sustainable development principles, the company is determined to create positive impact in the areas where it operates. The Bayer Group also aims to create value through innovation and growth and to increase its profitability and earning power. The Bayer brand represents trust, quality and reliability worldwide. As of fiscal year 2023, Bayer has more than 100,000 employees and sales revenue of EUR 47.6 billion, with R&D spending at EUR 5.8 billion.